The US Centers for Medicare and Medicaid Services on 28 February opened up a national coverage analysis tracking sheet on blood-based biomarker screening tests for colorectal cancer. The CMS tracking sheet was triggered by a request from Epigenomics to consider coverage of its Epi proColon assay.
In an April 2019
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?